de Almeida, Melanie http://orcid.org/0000-0003-4871-2069
Hinterndorfer, Matthias http://orcid.org/0000-0003-2435-4690
Brunner, Hanna http://orcid.org/0000-0002-3446-3738
Grishkovskaya, Irina http://orcid.org/0000-0003-0164-9373
Singh, Kashish http://orcid.org/0000-0002-9891-8148
Schleiffer, Alexander http://orcid.org/0000-0001-6251-2747
Jude, Julian
Deswal, Sumit
Kalis, Robert http://orcid.org/0000-0001-7553-4806
Vunjak, Milica http://orcid.org/0000-0001-6330-363X
Lendl, Thomas http://orcid.org/0000-0003-4596-9512
Imre, Richard
Roitinger, Elisabeth http://orcid.org/0000-0002-3405-7801
Neumann, Tobias http://orcid.org/0000-0003-3908-4224
Kandolf, Susanne http://orcid.org/0000-0002-4007-6283
Schutzbier, Michael
Mechtler, Karl http://orcid.org/0000-0002-3392-9946
Versteeg, Gijs A. http://orcid.org/0000-0002-6150-2165
Haselbach, David http://orcid.org/0000-0002-5276-5633
Zuber, Johannes http://orcid.org/0000-0001-8810-6835
Article History
Received: 25 March 2021
Accepted: 16 September 2021
First Online: 28 October 2021
Competing interests
: J.Z. is a founder, shareholder and scientific advisor of Quantro Therapeutics. J.Z., D.H. and the Zuber and Haselbach laboratories receive research support and funding from Boehringer Ingelheim. J.J. is now an employee of Twist Bioscience and T.N. is now an employee of Quantro Therapeutics. Other authors declare no competing interests.